Incyclix Bio, LLC

Pharmaceutical company · Durham, North Carolina, United States

Incyclix Bio, LLC is a pharmaceutical company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $11 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Incyclix Bio at a glance

Typepharmaceutical company

HeadquartersDurham, North Carolina, United States

Earliest incorporation on record2020

SEC CIK1916275

What does Incyclix Bio do?

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $11.2 million sold (2025).

Frequently asked questions about Incyclix Bio

Where is Incyclix Bio headquartered?

Incyclix Bio, LLC is headquartered in Durham, North Carolina, United States.

What does Incyclix Bio do?

Incyclix Bio, LLC is a pharmaceutical company.

When was Incyclix Bio founded?

The earliest incorporation on record for Incyclix Bio, LLC is in 2020, according to public company registers.

Similar companies

Opus Genetics, Inc.Durham, North Carolina, United States
Polarean, Inc.Durham, North Carolina, United States
T3D Therapeutics, Inc.Durham, North Carolina, United States
Chimerix IncDurham, North Carolina, United States
LadeRx, LLCDurham, North Carolina, United States
BioMarck Pharmaceuticals LtdDurham, North Carolina, United States
G1 Therapeutics, Inc.Durham, North Carolina, United States
Satsuma Pharmaceuticals, Inc.Durham, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences